Learn About Peripheral T-Cell Lymphoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Peripheral T-Cell Lymphoma Local Doctors?
JZ
Dr. Jasmine M. Zain
Hematology | Oncology | Hematology Oncology
Elite
Highly rated in
21
conditions
Hematology
Oncology
Hematology Oncology

Duarte

1500 E Duarte Rd 
Duarte, CA 91010

Jasmine Zain is a Hematologist and an Oncologist in Duarte, California. Dr. Zain has been practicing medicine for over 35 years and is rated as an Elite doctor by MediFind in the treatment of Peripheral T-Cell Lymphoma. She is also highly rated in 21 other conditions, according to our data. Her top areas of expertise are T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Anaplastic Large Cell Lymphoma, and Non-Hodgkin Lymphoma. She is licensed to treat patients in New York and California.

View Profile
EM
Enrica Marchi
Dr. Enrica Marchi
Oncology | Hematology
Elite
Highly rated in
7
conditions
Oncology
Hematology

UVA Health System

University Of Virginia Physicians Group

1240 Lee St 
Charlottesville, VA 22908

Enrica Marchi is an Oncologist and a Hematologist in Charlottesville, Virginia. Dr. Marchi has been practicing medicine for over 20 years and is rated as an Elite doctor by MediFind in the treatment of Peripheral T-Cell Lymphoma. She is also highly rated in 7 other conditions, according to our data. Her top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Testicular Cancer, and Non-Hodgkin Lymphoma. She is licensed to treat patients in Virginia. Dr. Marchi is currently accepting new patients.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
PP
Dr. Pierluigi I. Porcu
Oncology | Hematology Oncology
Elite
Highly rated in
28
conditions
Oncology
Hematology Oncology

Jefferson Health

Corporate Headquarters

925 Chestnut St 
Philadelphia, PA 19107

Pierluigi Porcu is an Oncologist and a Hematologist Oncology doctor in Philadelphia, Pennsylvania. Dr. Porcu has been practicing medicine for over 35 years and is rated as an Elite doctor by MediFind in the treatment of Peripheral T-Cell Lymphoma. He is also highly rated in 28 other conditions, according to our data. His top areas of expertise are Cutaneous T-Cell Lymphoma, T-Cell Lymphoma, Mycosis Fungoides, and Non-Hodgkin Lymphoma. He is licensed to treat patients in Pennsylvania and Ohio. Dr. Porcu is currently accepting new patients.

View Profile
View All Doctors
What are the Latest Advances for Peripheral T-Cell Lymphoma?
Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma.
Condition: Peripheral T-Cell Lymphoma (PTCL)
Journal: Frontiers in immunology
Treatment Used: Chemotherapy Combined with Chidamide vs. Chemotherapy
Number of Patients: 104
Published: February 21, 2022
View publication
Summary: Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma.
Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial.
Condition: Untreated Angioimmunoblastic T-cell Lymphoma in a Chinese Population
Journal: American journal of hematology
Treatment Used: Chidamide plus Prednisone, Etoposide, and Thalidomide
Number of Patients: 71
Published: February 16, 2022
View publication
Summary: Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial.
Tired of the same old research?
Check Latest Advances
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.
Condition: Primary Central Nervous System Lymphoma (PCNSL)
Journal: Blood
Treatment Used: Tisagenlecleucel
Number of Patients: 12
Published: February 15, 2022
View publication
Summary: Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.
View All Latest Advances
What are the latest Peripheral T-Cell Lymphoma Clinical Trials?
A Phase II Study of Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children
Who is this study for: Adult patients with Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Refractory Anemia, or Chronic Myelogenous Leukemia
Status: Active, not recruiting
Start Date: December 17, 2013
Intervention Type: Radiation, Procedure, Drug, Other, Biological
Study Drugs: Tacrolimus, Fludarabine
Phase: Phase 2
View Trial
Summary: This phase II trial studies how well T cell depleted donor peripheral blood stem cell transplant works in preventing graft-versus-host disease in younger patients with high risk hematologic malignancies. Giving chemotherapy and total-body irradiation before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells. It may also stop the patient's immune system from rejecti...
Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase I Dose-Escalation Study of CPI-613, in Combination With Bendamustine, in Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Classic Hodgkin Lymphoma
Who is this study for: Adult patients with Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Status: Active, not recruiting
Start Date: September 2014
Intervention Type: Drug
Study Drugs: Bendamustine
Phase: Phase 1
View Trial
Summary: This phase I trial studies the side effects and best dose of CPI-613 when given together with bendamustine hydrochloride in treating patients with relapsed or refractory T-cell non-Hodgkin lymphoma or Hodgkin lymphoma. CPI-613 may kill cancer cells by turning off their mitochondria, which are used by cancer cells to produce energy and are the building blocks needed to make more cancer cells. By sh...
View All Clinical Trials